Microvascular density and mast cells in benign and malignant pheochromocytomas

Polish Journal of Pathology

Volumn 63, Issue 4, 2012, Pages 235-242

  Białas, Magdalena ^a   Dyduch, Grzegorz ^a   Szpor, Joanna ^a   Demczuk, Sergiusz ^a   Okoń, Krzysztof ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Angiogenesis; Mast cells; Microvessels density; Pheochromocytoma

Indexed keywords

CD31 ANTIGEN; CELL SURFACE RECEPTOR; CHYMASE; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; TRYPTASE;

ADRENAL TUMOR; ARTICLE; BIOSYNTHESIS; HUMAN; IMMUNOHISTOCHEMISTRY; MAST CELL; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHEOCHROMOCYTOMA; VASCULARIZATION;

ADRENAL GLAND NEOPLASMS; ANTIGENS, CD; ANTIGENS, CD31; CHYMASES; HUMANS; IMMUNOHISTOCHEMISTRY; MAST CELLS; NEOVASCULARIZATION, PATHOLOGIC; PHEOCHROMOCYTOMA; RECEPTORS, CELL SURFACE; TRYPTASES;

EID: 84873835678     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: 10.5114/PJP.2012.32770     Document Type: Article

References (48)

1. Miettinen M. Paragangliomas in modern soft tissue pathology - tumors and non-neoplastic conditions. Cambridge University Press, New York 2010; 755-774.
2. McNicol AM. Update on tumours of adrenal cortex, pheochromocytoma and extra-adrenal paraganglioma. Histopathology 2011; 58: 155-168.
3. DeLellis RA, Lloyd RV, Heitz PU, et al. Tumours of endocrine organs - pathology and genetics, WHO classification of tumours. IARC Press, Lyon 2004; 147-158.
4. Thompson LD. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 2002; 26: 551-566.
5. Parenti G, Zampetti B, Rapizzi E, et al. Updated and new perspectives on diagnosis, prognosis and therapy of malignant pheochromocytoma/paraganglioma. J Oncol 2012; 2012: 872713.
6. Ribatti D, Crivellato E. Mast cells, angiogenesis and tumour growth. Biochim Biophys Acta 2012; 1822: 2-8.
7. Sharma S, Sharma MC, Sarkar C. Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 2005; 46: 481-489.
8. Vermeulen PB, Gasparini G, Fox SB, et al. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumors. Eur J Cancer 2002; 38: 1564-1579.
9. Tretiakova M, Antic T, Binder D, et al. Microvessel density is not increased in prostate cancer: digital imaging of routine sections and tissue microarrays. Hum Pathol 2012; doi: 10.1016/j.humpath.2012.06.009
10. Span PN, Rao JU, Oude Ophuis SB, et al. Overexpression of the natural antisense hypoxia-inducible factor-1alfa transcript is associated with malignant pheochromocytoma/paraganglioma. Endocr Relat Cancer 2011; 18: 323-331.
11. Kurban G, Hudon V, Duplan E, et al. Characterization of a von Hippel-Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis. Cancer Res 2006; 66: 1313-1319.
12. Favier J, Gimenez-Roqueplo AP. Pheochromocytomas: the (pseudo)-hypoxia hypothesis. Best Pract Res Clin Endocrinol Metab 2010; 24: 957-968.
13. Salmenkivi K, Heikkilä P, Liu J, et al. VEGF in 105 pheochromocytomas: enhanced expression correlates with malignant outcome. APMIS 2003; 111: 458-464.
14. Feng F, Zhu Y, Wang X, et al. Predictive factors for malignant pheochromocytoma: analysis of 136 patients. J Urol 2011; 185: 1583-1590.
15. Zielke A, Middeke M, Hoffmann S, et al. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors. Surgery 2002; 132: 1056-1063.
16. Favier J, Igaz P, Burnichon N, et al. Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma. Endocr Pathol 2012; 23: 34-42.
17. Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 2002; 94: 883-893.
18. Vartanian RK, Weidner N. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am J Pathol 1994; 144: 1188-1194.
19. Pezzella F, Pastorino U, Tagliabue E, et al. Non-small-cell lung carcinoma tumor growth without morphological evidence of neoangiogenesis. Am J Pathol 1997; 151: 1417-1423.
20. Delahunt B, Bethwaite PB, Thornton A. Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma. Br J Urol 1997; 80: 401-404.
21. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
22. Białas M, Okoń K, Czopek J. Assessing microvessel density in gastric carcinoma: a comparison of three markers. Pol J Pathol 2003; 54: 249-252.
23. Giatromanolaki A, Koukourakis MI, Sivridis E, et al. 'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behavior of non-small cell lung cancer. J Pathol 2000; 192: 140-149.
24. Liu Q, Djuricin G, Staren ED, et al. Tumor angiogenesis in pheochromocytomas and paragangliomas. Surgery 1996; 120: 938-943.
25. Rooijens PP, de Krijger RR, Bonjer HJ, et al. The significance of angiogenesis in malignant pheochromocytomas. Endocrine Pathol 2004; 15: 39-46.
26. Fox SB, Leek RD, Weekes MP, et al. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count and computer image analysis. J Pathol 1995; 177: 275-283.
27. Ohji H, Sasagawa I, Iciyanagi O, et al. Tumour angiogenesis and Ki-67 expression in pheochromocytoma. BJU Int 2001; 87: 381-385.
28. Kumar P, Wang JM, Bernabeu C. CD 105 and angiogenesis. J Pathol 1996; 178: 363-366.
29. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-257.
30. Fukumura D, Duda DG, Munn LL, Jain RK. Tumor microvasculature and microenvironment: novel insights through intravital imaging in preclinical models. Microcirculation 2010; 17: 206-225.
31. Jain RK. Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J Control Release 2001; 74: 7-25.
32. Markert EK, Levine AJ, Vazquez A. Proliferation and tissue remodeling in cancer: the hallmarks revisited. Cell Death Dis 2012; 3: e397.
33. Folberg R, Maniotis AJ. Vasculogenic mimicry. APMIS 2004; 112: 508-525.
34. Hollenberg NK. Implications of species difference for clinical investigation, studies on the renin-angiotensin system. Hypertension 2000; 35: 150-154.
35. Maltby S, Khazaie K, McNagny KM. Mast cells in tumor growth: angiogenesis, tissue remodeling and immune-modulation. Biochim Biophys Acta 2009; 1796: 19-26.
36. Crivellato E, Nico B, Ribatti D. Mast cell contribution to tumor angiogenesis: a clinical approach. Eur Cytokine Netw 2009; 20: 197-206.
37. Ranieri G, Ammendola M, Patruno R, et al. Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients. Int J Oncol 2009; 35: 115-120.
38. Ribatti D, Finato N, Crivellato E, et al. Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. Am J Obstet Gynecol 2005; 193: 1961-1965.
39. Ribatti D, Guidolin D, Marzullo A, et al. Mast cells and angiogenesis in gastric carcinoma. Int J Exp Pathol 2010; 91: 350-356.
40. Kondo K, Muramatsu M, Okamoto Y, et al. Expression of chymase-positive cells in gastric cancer and its correlation with the angiogenesis. J Surg Oncol 2006; 93: 36-43.
41. Wilk M, Liszka Ł, Paleń P, et al. Intensity of angiogenesis and mast cell infiltration in cervical intraepithelial and invasive lesions - are they correlated? Pathol Res Pract 2010; 206: 217-222.
42. Goksu Erol AY, Tokyol C, Ozdemir O, et al. The role of mast cells and angiogenesis in benign and malignant neoplasms of the uterus. Pathol Res Pract 2011; 207: 618-622.
43. Mohseni MG, Mohammadi A, Heshmat AS, et al. The lack of correlation between mast cells and microvessel density with pathologic feature of renal cell carcinoma. Int Urol Nephrol 2010; 42: 109-112.
44. Okoń K. Pathology of renal tumors in adults. Molecular biology, histopathological diagnosis and prognosis. Pol J Pathol 2008; 59: 129-176.
45. Ibaraki T, Muramatsu M, Takai S, et al. The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stageI non-small cell lung cancer. Eur J Cardiothorac Surg 2005; 28: 617-621.
46. Carlini MJ, Dalurzo MC, Lastiri JM, et al. Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance. Human Pathol 2010; 41: 697-705.
47. Dyduch G, Kaczmarczyk K, Okoń K. Mast cells and cancer: enemies or allies? Pol J Pathol 2012; 1: 1-7.
48. Dyduch G, Okoń K, Pescarini E. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study. Pol J Pathol 2011; 3: 139-144.